IRIS
CALABRESE, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.779
AS - Asia 2.596
EU - Europa 1.972
SA - Sud America 576
AF - Africa 160
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.090
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.677
SG - Singapore 873
RU - Federazione Russa 829
CN - Cina 688
BR - Brasile 460
IT - Italia 442
VN - Vietnam 306
KR - Corea 219
HK - Hong Kong 193
IE - Irlanda 168
IN - India 111
FI - Finlandia 91
ZA - Sudafrica 85
NL - Olanda 83
DE - Germania 81
FR - Francia 79
GB - Regno Unito 62
CA - Canada 44
MX - Messico 37
AR - Argentina 35
BD - Bangladesh 30
CI - Costa d'Avorio 30
KE - Kenya 25
AT - Austria 23
EC - Ecuador 22
JP - Giappone 22
ES - Italia 21
IQ - Iraq 20
PL - Polonia 18
SE - Svezia 17
ID - Indonesia 16
TR - Turchia 16
SA - Arabia Saudita 13
CO - Colombia 12
CL - Cile 11
PK - Pakistan 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
LT - Lituania 9
VE - Venezuela 9
JO - Giordania 7
PH - Filippine 7
IR - Iran 6
MY - Malesia 6
PE - Perù 6
UY - Uruguay 6
CH - Svizzera 5
PS - Palestinian Territory 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
PA - Panama 4
PT - Portogallo 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
MK - Macedonia 3
NP - Nepal 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
TW - Taiwan 3
UA - Ucraina 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
NG - Nigeria 2
OM - Oman 2
QA - Qatar 2
SI - Slovenia 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
DM - Dominica 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
GQ - Guinea Equatoriale 1
HR - Croazia 1
Totale 14.073
Salva come PNG Salva come JPEG
Città #
Dallas 7.581
Singapore 516
Hefei 340
Moscow 248
Seoul 216
Hong Kong 183
Santa Clara 176
Dublin 167
Beijing 145
Ashburn 116
Ho Chi Minh City 114
Milan 99
San Jose 85
Siena 76
Council Bluffs 73
Johannesburg 73
Hanoi 70
Los Angeles 68
The Dalles 61
Lauterbourg 52
Helsinki 48
Bengaluru 45
São Paulo 40
Haarlem 38
Florence 32
Abidjan 30
Munich 29
New York 29
Lappeenranta 28
Buffalo 27
Chicago 26
Redondo Beach 22
Nuremberg 21
Orem 20
Rome 18
Chennai 17
Rio de Janeiro 17
Frankfurt am Main 15
Turku 15
Amsterdam 14
Mexico City 14
Warsaw 13
Da Nang 12
Guayaquil 12
Houston 12
Hyderabad 12
London 12
Haiphong 11
Salt Lake City 11
Vienna 11
Columbus 10
Stockholm 10
Tokyo 10
Brno 9
Brooklyn 9
Manchester 9
Atlanta 8
Baghdad 8
Denver 8
Genoa 8
Montreal 8
Poplar 8
Toronto 8
Brasília 7
Ceggia 7
Curitiba 7
Hải Dương 7
Querétaro 7
Thái Bình 7
Amman 6
Bari 6
Belo Horizonte 6
Clifton 6
Goiânia 6
Guarulhos 6
Mumbai 6
Paris 6
Pisa 6
Recife 6
Salvador 6
Seravezza 6
Tehran 6
Asunción 5
Biên Hòa 5
Catania 5
Düsseldorf 5
Ha Long 5
Hillsboro 5
Lima 5
Nairobi 5
Ninh Bình 5
Ottawa 5
Phoenix 5
São Gonçalo 5
Tampa 5
Tashkent 5
Baku 4
Bangkok 4
Bogotá 4
Boston 4
Totale 11.429
Salva come PNG Salva come JPEG
Nome #
009 The transcriptome of Sweet syndrome suggests a pathogenic role of both innate and adaptive immune signaling pathways 7.207
Advances in the Pathogenesis and Treatment of Rosacea: A Phenotype-Based Therapeutic Approach 196
Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study 195
MAPK15 controls cellular responses to oxidative stress by regulating NRF2 activity and expression of its downstream target genes 188
Drug survival of biologics and non-biologics in patients affected by palmoplantar psoriasis: a "real-world", mono-center experience 169
Baricitinib: therapeutic potential for moderate to severe atopic dermatitis 168
Pso-Reg: a web registry for psoriasis in real life 152
Divergent in situ expression of IL-31 and IL-31RA between bullous pemphigoid and pemphigus vulgaris 150
Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose? 144
Characteristics of primary cutaneous lymphoma in Italy: a tertiary care, single-center study 138
Non-Invasive Imaging Including Line-Field Confocal Optical Coherence Tomography (LC-OCT) for Diagnosis of Cutaneous Lymphomas 138
Eyelid contact dermatitis: 25-year single-center retrospective study 137
Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin 136
Diffuse purpuric pityriasis versicolor: a peculiar presentation 135
Line-field confocal optical coherence tomography for the diagnosis of skin carcinomas: real-life data over three years 133
Clinical response to brodalumab in a patient affected by refractory SAPHO syndrome 132
Characterisation of IL-1 family members in Sweet syndrome highlights the overexpression of IL-1β and IL-1R3 as possible therapeutic targets 132
Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice 126
Erfolgreiche Behandlung des therapierefraktären Sweet-Syndroms mit Adalimumab 125
Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease 122
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still's Disease Registry 120
Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases* 118
Short-, mid- and long-term efficacy of dupilumab in moderate to severe atopic dermatitis: a real life multicenter Italian study on 2576 patients 118
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study 117
Signaling Pathways and Therapeutic Strategies in Advanced Basal Cell Carcinoma 116
Risk of Skin Cancer in Patients with Psoriasis: Single-Center Retrospective Study Comparing Anti-TNFα and Phototherapy 115
Belimumab as a potential therapeutic option for bullous systemic lupus erythematosus 113
Molecular Characteristics of Sweet Syndrome: A Systematic Review 113
Therapeutic Potential of Targeting the JAK/STAT Pathway in Psoriasis: Focus on TYK2 Inhibition 113
Erythema annulare centrifugum as clinical manifestation of-eosinophilic granulomatosis with polyangiitis 112
IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa 112
Italian Consensus on the treatment of oral lichen planus 112
Efficacy and safety of biologics for hidradenitis suppurativa: A network meta-analysis of phase III trials 109
Psoriasis and fibromyalgia: a systematic review 108
Line-field confocal optical coherence tomography in alopecia areata and histopathological correlation 107
Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg? 107
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 105
Investigational systemic drugs for moderate to severe plaque psoriasis: What’s new? 105
Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa 101
Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis 100
Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients 98
Overview of Atopic Dermatitis in Different Ethnic Groups 97
The role of NLRP1 inflammasome in skin cancer and inflammatory skin diseases 97
Tildrakizumab in moderate-to-severe plaque psoriasis: a multicenter, retrospective, real-life study 96
The corkscrew hairs of tinea capitis through line-field confocal optical coherence tomography 96
Psoriasis and its management in women of childbearing age: tools to increase awareness in dermatologists and patients 96
New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis 95
Fibromyalgia and Skin Disorders: A Systematic Review 93
Severe and resistant palmar psoriasis successfully treated with risankizumab 90
Use of JAK Inhibitors in Lichen Planus: An Update 90
Sweet syndrome: an update on clinical aspects, pathophysiology, and treatment 88
Paradoxical skin reaction to certolizumab, an overlap of neutrophilic dermatoses 87
Hyper-IgD syndrome and hidradenitis suppurativa: an intriguing link 87
725 Characterizing the transcriptional landscape of pyoderma gangrenosum and its main differential diagnoses 86
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies 86
From Bank Preparation to Clinical Use of Homologous Skin Allografts in Wound Healing: A Sustainable Approach 85
Design and development of a systematic validation protocol for synthetic melanoma images for responsible use in medical artificial intelligence 84
Successful treatment of pyoderma gangrenosum with composite grafting of acellular dermal matrix and glycerolized skin: a preliminary experience 82
Recalcitrant Sweet Syndrome successfully treated with adalimumab 82
Novel therapeutic strategies in the topical treatment of atopic dermatitis 77
Upadacitinib dose adjustment in moderate-to-severe atopic dermatitis: insights from a multicenter real-world study 70
117 Indiscernible skin transcriptome in Stevens-Johnson syndrome and toxic epidermal necrolysis induced by immune checkpoint inhibitors and other culprit drugs 67
Upadacitinib for Treatment-Resistant Urticarial Vasculitis: A Case Study and Therapeutic Insight 64
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry 56
Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry 55
T2-Reg: a regional web registry on Th2-mediated diseases 24
High-throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid 23
Abrocitinib: 1-Year Real-Life Experience From the French OMCCI Registry 4
Totale 14.399
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.127
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.127
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20232 0 0 0 0 0 0 0 0 0 0 0 2
2023/2024511 2 1 1 125 41 61 113 15 26 29 50 47
2024/20252.005 39 80 188 104 190 72 64 141 148 144 169 666
2025/202611.881 427 2.481 5.824 891 805 181 483 234 209 346 0 0
Totale 14.399